Lv11
60 积分 2024-03-01 加入
The Procalcitonin And Survival Study (PASS) – A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitoninand pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients
6小时前
待确认
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
6小时前
已完结
Artificial Extracellular Matrix Composed of Heparin-Mimicking Polymers for Efficient Anticoagulation and Promotion of Endothelial Cell Proliferation
4个月前
已完结
Nitric Oxide: A Guardian for Vascular Grafts?
7个月前
已完结
Advances in nitric oxide regulators for the treatment of ischemic stroke
7个月前
已完结
Acute Pancreatitis
7个月前
已完结
Deep Learning Models for Severity Prediction of Acute Pancreatitis in the Early Phase From Abdominal Nonenhanced Computed Tomography Images
8个月前
已完结
Real‐time artificial intelligence predicts adverse outcomes in acute pancreatitis in the emergency department: Comparison with clinical decision rule
8个月前
已完结
Machine learning improves prediction of severity and outcomes of acute pancreatitis: a prospective multi-center cohort study
8个月前
已完结
Diagnosis and Management of Acute Pancreatitis
8个月前
已完结
皖公网安备34019202002308
